COVID is here to stay: countries must decide how to adapt.

Nature ; 601(7892): 165, 2022 01.

Article in English | MEDLINE | ID: covidwho-1616967

Subject(s)

COVID-19/epidemiology; International Cooperation; SARS-CoV-2/isolation & purification; Adaptation, Psychological; Adult; COVID-19/prevention & control; COVID-19 Vaccines/economics; COVID-19 Vaccines/supply & distribution; Child; Cytidine/analogs & derivatives; Cytidine/therapeutic use; Drug Combinations; Endemic Diseases/statistics & numerical data; Humans; Hydroxylamines/therapeutic use; Immunity, Herd; Immunization, Secondary; Lactams/therapeutic use; Leucine/therapeutic use; Nitriles/therapeutic use; Physical Distancing; Proline/therapeutic use; Reinfection/epidemiology; Reinfection/virology; Ritonavir/therapeutic use; SARS-CoV-2/genetics; SARS-CoV-2/immunology; SARS-CoV-2/pathogenicity; Social Change; South Africa/epidemiology; COVID-19 Drug Treatment

Keywords

Epidemiology; Public health; SARS-CoV-2; Vaccines

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 / International Cooperation Type of study: Observational study Topics: Vaccines Limits: Adult / Child / Humans Country/Region as subject: Africa Language: English Journal: Nature Year: 2022 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google